View the AMOXICAP 250 registration information details.
Back to drug list
ItemsDrug Registration information
ID284
No284
Brand NameAMOXICAP 250
IngredientsAMOXYCILLIN TRIHYDRATE EQ.TO AMOXYCILLIN 250 MG
Dosage FormCAPSULE
Primary PackagingPVC/ALU BLISTER
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 10 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsEAR, NOSE AND THROAT INFECTIONS CAUSED BY STREPTOCOCCI, PNEUMOCOCCI, NON-PENICILLINASE-PRODUCING STAPHYLOCOCCI AND H.INFLUENZA, GENITOURINARY TRACT INFECTION CAUSED BY E.COLI, P.MIRABILIS, S.FAECALIS, SKIN AND SOFT TISSUE INFECTION CAUSED BY STREPTOCOCCI, NON-PENICILLINASE-PRODUCING STAPHYLOCOCCI AND E.COLI, ANOGENITAL AND URETHRAL GONORRHOEA CAUSED BY N.GONORRHOEA
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionSCARLET AND GREY CAPSULE WITH AX250 PRINTED ON ONE END AND HD PRINTED ON THE OTHER END, FILL MATERIAL: OFF-WHITE TO YELLOWISH POWDER
Note
License OwnerBMS PHARMA SOLE CO.,LTD
ManufacturerHOVID BHD
CountryMALAYSIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No08 I 5270/22
FDD Registration Date09/06/2025
Expiry Date08/06/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA